Details of the Drug Formulaction

General Information of Drug Formulation (ID: F16018)

• Formulation Name: Ondansetron 8 mg tablet
• Company: Lake Eire Medical & Surgical Supply DBA Quality Care Products; Physicians Total Care; Rebel Distributors

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ondansetron	(DMOTQ1I)	Chemotherapy-induced nausea	MD90	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 400	(E00653)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent